BG Medicine IncOver The Counter Market:BGMD
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BG Medicine Inc | 10.0 | 0.0x | --- |
Montvale Technologies Inc | 10.0 | 0.0x | --- |
DiaSys Corp | 2.6K | 0.0x | --- |
Healthtech Solutions Inc | 9.6K | 0.0x | --- |
Electromedical Technologies Inc | 342.0K | -0.1x | --- |
QHSLab Inc | 868.3K | -4.3x | --- |
Company Information
BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Contact Information
- Headquarters
- 880 Winter Street, Suite 210WALTHAM, MA, United States 02451
- Phone
- 781-890-1199
- Fax
- 302-636-5454
Executives
- Chairman of the Board
- Harry Wilcox
- President, Chief Executive Officer, Director
- Paul Sohmer
- Chief Financial Officer, Executive Vice President, Treasurer
- Stephen Hall
- Senior Vice President, Chief Scientific Officer
- Aram Adourian
- Independent Director
- Jeffrey Luber
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
|---|---|
Revenue (TTM) | $1.6M |
Shares Outstanding | 11.4M |
BG Medicine Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.74 |
Book Value | $0.05 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -295.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
